Etentamig, Dexamethasone, Daratumumab, Cyclophosphamide, Bortezomib
Amyloid Light Chain (Al) Amyloidosis
Phase III
Not Yet Recruiting
Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) Amyloidosis
Aug 26, 2026
Carboplatin, Pembrolizumab, Paclitaxel, Abbv-1480, Nab- Paclitaxel
Non-small Cell Lung Cancer
Phase III
Not Yet Recruiting
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants
Aug 07, 2026
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AbbVie (ABBV) have in its pipeline
ABBV is currently developing the following drugs: Etentamig, Dexamethasone, Daratumumab, Cyclophosphamide, Bortezomib, Upadacitinib, Carboplatin, Pembrolizumab, Paclitaxel, Abbv-1480, Nab- Paclitaxel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.